TY - JOUR
T1 - Cancer in Syrian refugees in Jordan and Lebanon between 2015 and 2017
AU - Spiegel, Paul B.
AU - Cheaib, Joseph G.
AU - Aziz, Saad Abdel
AU - Abrahim, Orit
AU - Woodman, Michael
AU - Khalifa, Adam
AU - Jang, Minyoung
AU - Mateen, Farrah J.
N1 - Funding Information:
FJM reports grant funding from the National Institutes of Health, the National Multiple Sclerosis Society, Fondation Pierre Fabre, the Charles Hood Foundation, and IQVIA (Health Outcomes), and personal consulting fees from the Gerson Lehrman Group, Genentech, and Biogen, outside of the submitted work. All other authors declare no competing interests.
PY - 2020/5
Y1 - 2020/5
N2 - Protracted conflicts in the Middle East have led to successive waves of refugees crossing borders. Chronic, non-communicable diseases are now recognised as diseases that need to be addressed in such crises. Cancer, in particular, with its costly, multidisciplinary care, poses considerable financial and ethical challenges for policy makers. In 2014 and with funding from the United Nations High Commissioner for Refugees, we reported on cancer cases among Iraqi refugees in Jordan (2010–12) and Syria (2009–11). In this Policy Review, we provide data on 733 refugees referred to the United Nations High Commissioner for Refugees in Lebanon (2015–17) and Jordan (2016–17), analysed by cancer type, demographic risk factors, treatment coverage status, and cost. Results show the need for increased funding and evidence-based standard operating procedures across countries to ensure that patients have equitable access to care. We recommend a holistic response to humanitarian crises that includes education, screening, treatment, and palliative care for refugees and nationals and prioritises breast cancer and childhood cancers.
AB - Protracted conflicts in the Middle East have led to successive waves of refugees crossing borders. Chronic, non-communicable diseases are now recognised as diseases that need to be addressed in such crises. Cancer, in particular, with its costly, multidisciplinary care, poses considerable financial and ethical challenges for policy makers. In 2014 and with funding from the United Nations High Commissioner for Refugees, we reported on cancer cases among Iraqi refugees in Jordan (2010–12) and Syria (2009–11). In this Policy Review, we provide data on 733 refugees referred to the United Nations High Commissioner for Refugees in Lebanon (2015–17) and Jordan (2016–17), analysed by cancer type, demographic risk factors, treatment coverage status, and cost. Results show the need for increased funding and evidence-based standard operating procedures across countries to ensure that patients have equitable access to care. We recommend a holistic response to humanitarian crises that includes education, screening, treatment, and palliative care for refugees and nationals and prioritises breast cancer and childhood cancers.
UR - http://www.scopus.com/inward/record.url?scp=85083860027&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083860027&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(20)30160-1
DO - 10.1016/S1470-2045(20)30160-1
M3 - Review article
C2 - 32359503
AN - SCOPUS:85083860027
VL - 21
SP - e280-e291
JO - The Lancet Oncology
JF - The Lancet Oncology
SN - 1470-2045
IS - 5
ER -